Search results
Results from the WOW.Com Content Network
1950s According to the 2016 lawsuit brought against 3M by Lake Elmo, Minnesota, 3M had "disposed of PFCs and PFC-containing waste at a facility it owned and operated in Oakdale, Minnesota (the "Oakdale Facilities")" during the 1950s. [18] [19] 1951 "The DuPont chemical plant in Washington, West Virginia, began using PFOA in its manufacturing ...
Poly drug use often carries more risk than use of a single drug, due to an increase in side effects, and drug synergy. For example, the chance of death from overdosing on opiates is greatly increased when they are consumed in conjunction with alcohol. [2] While they are two distinct phenomena, deaths from CDI are often misreported as overdoses. [3]
Sinaltrainal v. Coca-Cola, 578 F.3d 1252 (11th Cir. 2009), was a case in which the United States Court of Appeals for the Eleventh Circuit upheld the dismissal of a case filed by Colombian trade union Sinaltrainal (National Union of Food Workers) against Coca-Cola in a Miami district court, demanding monetary compensation of $500 million under the Alien Tort Claims Act for the deaths of three ...
Sen. Charles Schumer, D-N.Y., called on the Food and Drug Administration (FDA) to investigate Prime energy drinks in 2023 because of dangerously high caffeine levels. Schumer alleged in a letter ...
For premium support please call: 800-290-4726 more ways to reach us
Nov. 13—A Westmoreland County judge on Monday dismissed criminal charges against a Southwest Greensburg woman who prosecutors said was responsible for the fatal overdose of her live-in boyfriend ...
The United States Environmental Protection Agency (EPA) defines PFAS in the Drinking Water Contaminant Candidate List 5 as substances that contain "at least one of the following three structures: R−CF 2 −CF(R')R", where both the −CF 2 − and −CF− moieties are saturated carbons, and none of the R groups can be hydrogen; R−CF 2 −O ...
The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...